Crane Biosciences

Solving in-vivo delivery. Curing genetic diseases.
Founded 2022
Founders Luca Bolondi, CEO, Crane Biosciences Sujaan Das, CTO, Crane Biosciences
Biotechnology

Over 80% of all diseases are caused by genetic mutations. These diseases cause over 44M deaths a year.

Gene therapies could offer a cure and save millions of people. However, over 99% of clinical trials fail, mostly due to problems with a single key component: the in-vivo delivery system.

We are creating an ML-powered bio-platform to solve targeted delivery and make gene therapies much more likely to succeed. We have already shown promising pre-clinical results.

Our advisors include a Director of the Gene Center Munich, the Science Chair at the International Society for Extracellular Vesicles, and an ex-GP at Speedinvest.

Founders

Luca
Bolondi

CEO, Crane Biosciences

Engineer experienced in growing deeptech startups, raised >$1M. Spent >1000hrs learning biotech.

Linkedin

Sujaan
Das

CTO, Crane Biosciences

Biochem PhD at the Crick Institute, Curie Fellow. Experience in biochemical processing of cells.

Linkedin

Related

Biotechnology
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
Climate or EnvironmentEnergySustainability
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Healthcare
AccuRx

AccuRx

Powering communications in the healthcare sector.
Healthcare
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.
Manufacturing or Industrial
Adelántalo

Adelántalo

Factoring 2.0 for Trucking in LATAM.
B2BFinanceSupply Chain, Transportation or Logistics
Affable

Affable

Leverage AI for your Influencer Marketing Campaigns.
Advertising/Marketing